2019 PACS and RIS Market Immense Growth Potential and Global Forecast by 2027 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

2019 PACS and RIS Market Immense Growth Potential and Global Forecast by 2027

Description:

According to a new market research study titled ‘PACS and RIS Market to 2027 – Global Analysis and Forecasts by Product, Component, Deployment, and End User.’ The Global PACS and RIS Market is expected to reach US$ 5,008.93 Mn in 2027 from US$ 2,728.43 Mn in 2018. The market is estimated to grow with a CAGR of 7.4% from 2019-2027. The report highlights the trends prevalent in the global PACS and RIS market and the factors driving the market along with those that act as deterrents to its growth. Download Sample Report at – PowerPoint PPT presentation

Number of Views:15

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: 2019 PACS and RIS Market Immense Growth Potential and Global Forecast by 2027


1
PACS and RIS Market
Publication Month Jul 2019 Report Code
TIPRE00003005 No. of Pages 177 Category
Healthcare IT Status Published
PACS and RIS Market to 2025 - Global Analysis and
Forecasts by Product (Intermittent Catheters,
Urinary Bags, Male External Catheters, Bowel
Management, Others) Applications (Spinal Cord
Injury, Benign Prostate Hyperplasia, Others) and
End Users (Long-Term Care Facilities, Hospitals,
and Others)
E-Mail  sales_at_theinsightpartners.com
2
PACS and RIS Market
Publication Month Jul 2019 Report Code
TIPRE00003005 No. of Pages 177 Category
Healthcare IT Status Published
Introduction The global PACS and RIS market
expected to be US 2,728.43 Mn in 2018 and is
predicted to grow at a CAGR of 7.4 during the
forecast period 2019 2027, to reach US
5,008.93 Mn by 2027.   Europe is the second
largest geographic market and is expected to be
the second most significant revenue contributor
throughout the forecast period. The region has
witnessed several technological advancements in
the field of healthcare by the incorporation of
digital technology in order to increase the
efficiency of healthcare facilities in the
region. The growth is driven by factors such as
government collaborations with technology
providers, prevalence of cancer in the countries.
E-Mail  sales_at_theinsightpartners.com
3
PACS and RIS Market
Publication Month Jul 2019 Report Code
TIPRE00003005 No. of Pages 177 Category
Healthcare IT Status Published
Developments in Diagnostic Imaging Modalities
Coupled with Rising Number of Diagnostic Tests
Procedures   Medical imaging is a vital part in
medical care and treatment across the globe.
Rising awareness regarding early diagnosis of
diseases has led to an increase in the total
number of diagnostic tests procedures performed
around the world. During the year 2012, Canadians
underwent 1.7 million magnetic resonance imaging
(MRI) exams and 4.4 million computed tomographies
(CT) exams. The statistics reveal, nearly double
the number of such reviews performed during 2003.
The national rate for CT scans were 126 per 1,000
individuals around 2014 and 2015. Rates ranged
from 209 (New Brunswick) and 170 (Newfoundland
and Labrador) to 88 (Alberta) and 93 (Prince
Edward Island). In addition, according to the
National Health Services (NHS) UK, there were 4.1
million imaging tests conducted in England in the
12 months from February 2016 to January 2017. Of
these, 3.49 million imaging tests were reported
to have taken place in January 2017.   As per the
World Health Organization (WHO), with improved
health care policy and the better availability of
medical equipment, there has been rise in the
number of global imaging-based procedures. Thus,
the growing number of diagnostic imaging
procedures performed across the globe resulting
in increasing requirement of consumables for
tests are likely expected to drive the growth of
the global PACS and RIS market over the coming
years.
E-Mail  sales_at_theinsightpartners.com
4
PACS and RIS Market
Publication Month Jul 2019 Report Code
TIPRE00003005 No. of Pages 177 Category
Healthcare IT Status Published
New Product Launches FDA Approvals Frequent FDA
approvals and product launches drive the market
for PACS and RIS. Most of the major market
players operating in the market are adopting
measures such as product launches as well as
approvals to provide a better solution as well as
software in the PACS and RIS market. For
instance, during February 2019, Philips
introduced IntelliSpace Cardiovascular 4.1, a
cardiovascular image and information management
system. The platform offers efficient pediatric
reporting capabilities. With the rising
prevalence of cardiovascular disorders, the
launch of software can enable better treatment as
well as diagnosis of these disorders.   Also, in
June 2017, FDA approved IntelliSpace Portal 9.0
provided by Philips to be commercialized in the
U.S. The system offers more than 70 applications
in the field of radiology, such as oncology
cardiology, and neurology. The platform provides
clinicians a better overview of every patient,
helping in quick diagnosis with the help of
multimodality clinical applications developed for
evaluation of patient data. The excellent
benefits provided by these newly approved as well
as launched products are expected to drive the
demand for the market during the forecast
period.
Get Sample Brochure
E-Mail  sales_at_theinsightpartners.com
5
PACS and RIS Market
Publication Month Jul 2019 Report Code
TIPRE00003005 No. of Pages 177 Category
Healthcare IT Status Published
  • The List of Companies
  • McKesson Corporation
  • General Electric
  • Fujifilm Holdings Corporation
  • Koninklijke Philips N.V.
  • Siemens AG
  • Cerner Corporation
  • IBM
  • Novarad
  • Agfa-Gevaert Group
  • INFINITT Healthcare Co., Ltd.
  • Inquire more _at_ https//www.theinsightpartners.com/
    inquiry/TIPRE00003005

E-Mail  sales_at_theinsightpartners.com
About PowerShow.com